scispace - formally typeset
D

David Baltimore

Researcher at California Institute of Technology

Publications -  882
Citations -  168784

David Baltimore is an academic researcher from California Institute of Technology. The author has contributed to research in topics: RNA & Virus. The author has an hindex of 203, co-authored 876 publications receiving 162955 citations. Previous affiliations of David Baltimore include Thomas Jefferson University & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids.

TL;DR: A serum-free, artificial thymic organoid (ATO) system that supports efficient and reproducible in vitro differentiation and positive selection of conventional human T cells from all sources of HSPCs is described.
Journal ArticleDOI

The combined absence of the transcription factors Rel and RelA leads to multiple hemopoietic cell defects

TL;DR: Data indicate the loss of Rel andrelA does not appear to affect pluripotent stem cells; rather, Rel and RelA serve redundant functions in regulating differentiation and survival of committed progenitors in multiple hemopoietic lineages.
Journal ArticleDOI

E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice.

TL;DR: The results demonstrate a causative role for p85E2A-Pbx1 in human acute leukemia and indicate that the oncogenic potential of PbX1 is not limited to pre-B-cell malignancies.
Journal ArticleDOI

Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A

TL;DR: Investigating the mechanism by which miR-125b regulates hematopoiesis, it was found that, among a panel of candidate targets, the mRNA for Lin28A, an induced pluripotent stem cell gene, was most repressed by miR -125b in mouse hematoietic stem and progenitor cells.
Journal ArticleDOI

Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation.

TL;DR: Systematic deletion of v-abl sequences showed that only 45,000 to the 130,000 molecular weight ofv-abl sequence in the A-MuLV protein is needed for fibroblast transformation and, at most, slightly more is neededFor lymphoid cell transformation.